Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K. Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K. SOPHiA GENETICS Reports First Quarter 2026 Results SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026 Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan SOPHiA GENETICS gibt vorläufige Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2025 bekannt, veröffentlicht Prognose für 2026 und kündigt Plan für Wechsel in der Geschäftsführung an SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave